ArticleCureus2026
Developing an AI-Based Model for Lagophthalmos and Bell's Phenomenon Detection in Intensive Care Unit Patients: A Gold Standard Comparison.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To validate a newly developed artificial intelligence (AI) model as a screening tool for detecting lagophthalmos and poor Bell's phenomenon, by comparing its performance with the gold-standard examination conducted by an ophthalmologist. Design A cross-sectional observational study was conducted. External eye photographs of patients admitted to intensive care units at a secondary hospital in Taif City, Kingdom of Saudi Arabia, were analyzed by the AI model to detect lagophthalmos and assess Bell's phenomenon. Conclusions and importance The findings of this study have the potential to significantly impact healthcare by enabling the prediction of serious ocular complications through an AI-based screening model for ICU patients. The integration of AI models can improve patient screening, facilitating early preventive measures such as lid tapes and lubricants to reduce the occurrence of exposure keratopathy. If validated, this AI model could be effectively utilized by non-ophthalmologist staff, including ICU nurses, thereby promoting earlier detection of lagophthalmos and preventing prolonged corneal exposure, which is a known risk factor for exposure keratopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.